We showed, by PCR amplification of specific antibody gene regions deriving from ten primary breast tumors (none being of the rare MBC histological type) of patients aged between 49–79 years, that seven of ten of these samples (70%), have a prominent IgG antibody expression, as compared with the IgA subclass. The gene discussed is CD79A; the disease is breast neoplasm.